ID   UKWi001-A
AC   CVCL_RJ97
SY   SLC2A3-D2-iPSC
DR   hPSCreg; UKWi001-A
DR   SKIP; SKIP003161
DR   Wikidata; Q54990716
RX   PubMed=29477591;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Sequence variation: Gene amplification; HGNC; 11007; SLC2A3; Duplication; Zygosity=Unspecified (PubMed=29477591).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
RX   PubMed=29477591; DOI=10.1016/j.scr.2018.02.005;
RA   Jansch C., Gunther K., Waider J., Ziegler G.C., Forero A., Kollert S.,
RA   Svirin E., Puhringer D., Kwok C.K., Ullmann R., Maierhofer A.,
RA   Flunkert J., Haaf T., Edenhofer F., Lesch K.-P.;
RT   "Generation of a human induced pluripotent stem cell (iPSC) line from
RT   a 51-year-old female with attention-deficit/hyperactivity disorder
RT   (ADHD) carrying a duplication of SLC2A3.";
RL   Stem Cell Res. 28:136-140(2018).
//